Pages that link to "Q37022228"

The following pages link to Dendritic cells and cytokines in immune rejection of cancer. (Q37022228):

Displaying 25 items.

• Tumor cell lysates as immunogenic sources for cancer vaccine design (Q28083469) (← links)
• Monocyte-derived dendritic cells from patients with cervical intraepithelial lesions (Q33598313) (← links)
• Chimeric NKG2D T cells require both T cell- and host-derived cytokine secretion and perforin expression to increase tumor antigen presentation and systemic immunity (Q33671322) (← links)
• Tumor vaccine composed of C-class CpG oligodeoxynucleotides and irradiated tumor cells induces long-term antitumor immunity (Q33690978) (← links)
• Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis (Q33762632) (← links)
• Interferon-α-conditioned human monocytes combine a Th1-orienting attitude with the induction of autologous Th17 responses: role of IL-23 and IL-12. (Q33840997) (← links)
• USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon α response (Q33968305) (← links)
• mda-7/IL-24: A unique member of the IL-10 gene family promoting cancer-targeted toxicity (Q35189796) (← links)
• Glycogen Synthase Kinase-3β (GSK-3β) Inhibition Enhances Dendritic Cell-based Cancer Vaccine Potency via Suppression of Interferon-γ-induced Indoleamine 2,3-Dioxygenase Expression (Q35583214) (← links)
• Erlotinib protects against LPS-induced endotoxicity because TLR4 needs EGFR to signal (Q35946356) (← links)
• Clinical response of advanced cancer patients to cellular immunotherapy and intensity-modulated radiation therapy (Q37381085) (← links)
• Preimmunization of donor lymphocytes enhances antitumor immunity of autologous hematopoietic stem cell transplantation (Q37482548) (← links)
• Chronic Inflammation: Synergistic Interactions of Recruiting Macrophages (TAMs) and Eosinophils (Eos) with Host Mast Cells (MCs) and Tumorigenesis in CALTs. M-CSF, Suitable Biomarker for Cancer Diagnosis! (Q37693490) (← links)
• Type I interferons in systemic autoimmunity (Q37713727) (← links)
• Combination of intensive chemotherapy and anticancer vaccines in the treatment of human malignancies: the hematological experience (Q37772085) (← links)
• In vivo delivery of interferon-α gene enhances tumor immunity and suppresses immunotolerance in reconstituted lymphopenic hosts (Q39536228) (← links)
• Therapeutic response in patients with advanced malignancies treated with combined dendritic cell-activated T cell based immunotherapy and intensity-modulated radiotherapy (Q42093293) (← links)
• Enhancement of anti-Aspergillus T helper type 1 response by interferon-β-conditioned dendritic cells (Q42662541) (← links)
• DC maturation and function are not altered by melanoma-derived immunosuppressive soluble factors (Q43136973) (← links)
• Toll-like receptor (TLR) expression of immune system cells from metastatic breast cancer patients with circulating tumor cells (Q45273801) (← links)
• Spontaneous regression of highly immunogenic Molluscum contagiosum virus (MCV)-induced skin lesions is associated with plasmacytoid dendritic cells and IFN-DC infiltration (Q45373465) (← links)
• Uncovering the underlying mechanism of cancer tumorigenesis and development under an immune microenvironment from global quantification of the landscape (Q48058780) (← links)
• Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence (Q54404821) (← links)
• Proteomic Identification of Heat Shock-Induced Danger Signals in a Melanoma Cell Lysate Used in Dendritic Cell-Based Cancer Immunotherapy. (Q55221792) (← links)
• Alloreactive cytotoxic T lymphocyte immunotherapy treatment of a patient with metastatic prostate cancer: A case report. (Q55403719) (← links)